The Cooper Companies, Inc. (NASDAQ:COO) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have earned an average rating of “Moderate Buy” from the twelve brokerages that are presently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $117.00.

COO has been the subject of a number of analyst reports. Wells Fargo & Company upped their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Piper Sandler increased their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Finally, Morgan Stanley lowered their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th.

Hedge Funds Weigh In On Cooper Companies

Several hedge funds have recently made changes to their positions in COO. Principal Financial Group Inc. grew its stake in Cooper Companies by 6.6% during the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock valued at $26,295,000 after purchasing an additional 14,687 shares during the last quarter. Lord Abbett & CO. LLC lifted its holdings in shares of Cooper Companies by 6.3% during the third quarter. Lord Abbett & CO. LLC now owns 251,402 shares of the medical device company’s stock worth $27,740,000 after purchasing an additional 14,957 shares during the period. Franklin Resources Inc. boosted its position in Cooper Companies by 194.0% in the third quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock valued at $5,265,000 after buying an additional 32,260 shares during the last quarter. Synovus Financial Corp increased its holdings in Cooper Companies by 18.8% in the 3rd quarter. Synovus Financial Corp now owns 31,568 shares of the medical device company’s stock worth $3,483,000 after buying an additional 4,987 shares during the period. Finally, Tidal Investments LLC raised its position in Cooper Companies by 7.8% during the 3rd quarter. Tidal Investments LLC now owns 14,369 shares of the medical device company’s stock worth $1,585,000 after buying an additional 1,043 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Trading Up 1.6 %

NASDAQ COO opened at $93.44 on Friday. The company’s 50-day simple moving average is $102.20 and its two-hundred day simple moving average is $98.89. Cooper Companies has a one year low of $84.76 and a one year high of $112.38. The company has a market capitalization of $18.65 billion, a price-to-earnings ratio of 47.92, a price-to-earnings-growth ratio of 2.52 and a beta of 0.97. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Cooper Companies’s revenue was up 9.8% compared to the same quarter last year. During the same period last year, the company posted $0.87 earnings per share. Equities analysts forecast that Cooper Companies will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.